167355-41-1

Basic information

• Product Name: 6-Bromo-1,2,3,4-tetrahydronaphthalen-2-amine
• Synonyms: 6-BROMO-1,2,3,4-TETRAHYDRO-NAPHTHALEN-2-YLAMINE;6-BROMO-1,2,3,4-TETRAHYDRO-NAPHTHALEN-2-YLAMINE HYDROCHLORIDE;6-Bromo-1,2,3,4-tetrahydronaphthalen-2-amine;2-Amino-6-bromo-1,2,3,4-tetrahydronaphthalene;6-bromo-1,2,3,4-tetrahydro-2-Naphthalenamine
• CAS NO: 167355-41-1
• Molecular Formula: C₁₀H₁₂BrN
• Molecular Weight: 226.11
• Mol File: 167355-41-1.mol
• Article Data: 14

Chemical Properties

• Boiling Point: 298.704°C at 760 mmHg
• Flash Point: 134.452°C
• Appearance: /
• Density: 1.413g/cm³
• Vapor Pressure: 0.001mmHg at 25°C
• Refractive Index: 1.594
• Storage Temp.: 2-8°C(protect from light)
• PKA: 10.02±0.20(Predicted)
• CAS DataBase Reference: 6-Bromo-1,2,3,4-tetrahydronaphthalen-2-amine(CAS DataBase Reference)
• NIST Chemistry Reference: 6-Bromo-1,2,3,4-tetrahydronaphthalen-2-amine(167355-41-1)
• EPA Substance Registry System: 6-Bromo-1,2,3,4-tetrahydronaphthalen-2-amine(167355-41-1)

Safety Data

• Hazardous Substances Data: 167355-41-1(Hazardous Substances Data)

Usage

General Description

6-Bromo-1,2,3,4-tetrahydronaphthalen-2-amine, also known as 6-Bromo-2-aminoindane, is a chemical compound with the molecular formula C10H11BrN. It is a derivative of the amphetamine analog, 2-Aminoindane. 6-Bromo-1,2,3,4-tetrahydronaphthalen-2-amine has been studied for its potential use as a psychoactive substance and has shown dopaminergic and serotonergic effects in animal studies. It is considered a research chemical and is not approved for human consumption. It is important to handle this compound with care and follow proper safety precautions when working with it in a laboratory setting.

InChI:InChI=1/C10H12BrN/c11-9-3-1-8-6-10(12)4-2-7(8)5-9/h1,3,5,10H,2,4,6,12H2

Upstream product

• 4133-35-1 6-bromo-2-tetralone 
• 133277-09-5 6-bromo-2-oximino-1,2,3,4-tetrahydronaphthalene 

Relevant articles and documents

CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS

The present disclosure relates to modulators, such as inhibitors, of at least one pathway chosen from USP28 and USP25, pharmaceutical compositions comprising the inhibitors, and methods of using the inhibitors. The modulators, such as inhibitors, of at least one pathway chosen from USP28 and USP25 can be useful in the treatment of cancers, among other ailments.

MOLECULES HAVING CERTAIN PESTICIDAL UTILITIES, AND INTERMEDIATES, COMPOSITIONS, AND PROCESSES RELATED THERETO

This disclosure relates to the field of molecules having pesticidal utility against pests in Phyla Nematoda, Arthropoda, and/or Mollusca, processes to produce such molecules and intermediates used in such processes, compositions containing such molecules,

Oxadiazole derivatives as S1P1 receptor agonists

New compounds having the chemical structure of formula (I) or pharmaceutically acceptable salts or N-oxides thereof wherein A is selected from the group consisting of -N-, -O- and -S-; B and C independently are selected from the group consisting of -N- and -O-, with the proviso that at least two of A, B and C are nitrogen atoms; G1 is selected from the group consisting of nitrogen atoms and -CRC- groups, wherein RC represents a hydrogen atom, a halogen atom, a C1-4 alkyl group or a C1-4 alkoxy group; R1 is selected from the group consisting of hydrogen atoms, C1-4 alkyl groups, C1-4 alkoxy groups, C3-4 cycloalkyl groups, and -NRdRe groups wherein Rd and Re are independently selected from hydrogen atoms and C1-4 alkyl groups; R2 and R3 are independently selected from the group consisting of hydrogen atoms and C1-4 alkyl groups; R4, R5 and R7 are independently selected from the group consisting of hydrogen atoms, halogen atoms, C1-4 alkyl groups, C1-4 alkoxy groups and C1-4 haloalkyl groups; R6 represents a C1-4 alkyl group or a C1-4 hydroxyalkyl group; or R6 is selected from the group consisting of -S(O)2-NRaRb groups, -(CRfRg)n-(CRhRi)x-(CRjRk)y-NRaRb groups, -(CH2)n-NRaRb groups, -O-(CH2)n-NRaRb groups, -(CH2)n-COOH groups, -(CH2)n-NRa-CO-Rb' groups, -(CH2)n-NRa-(CH2)p-(NH)q-SO-CH3 groups and -(CH2)n-CO-NRaRb groups, wherein n, p, x and y are each independently integers from 0 to 3, q is 0 or 1, Rf, Rg, Rh, Ri, Rj and Rk independently represent hydrogen atoms or halogen atoms, Rb' is selected from the group consisting of methylsulphonyl groups, C1-4 alkyl groups, C1-4 hydroxyalkyl groups, C1-4 carboxyalkyl groups, and C1-4 haloalkyl groups; Ra and Rb are independently selected from the group consisting of hydrogen atoms, methylsulphonyl groups, C1-4 alkyl groups, C1-4 hydroxyalkyl groups, C1-4 carboxyalkyl groups, and C1-4 haloalkyl groups, or Ra and Rb together with the nitrogen atom to which they are attached form a 4 to 6 membered, saturated heterocyclic group, which contains, as heteroatoms, one or two nitrogen atoms and which is substituted by a carboxyl group or a C1-4 carboxyalkyl group; or Rc together with R6 form a C5-8 carbocyclic ring optionally substituted by - NHR' wherein R' represents a hydrogen atom or a 61-4 carboxyalkyl group.